Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	64.93	93.78	56.86
Graham Fair Price	-52.78	19.87	42.08
PEG	2209.67	-1.98	0.09
Price/Book	19.40	2.45	2.05
Price/Cash Flow	-6.34	-47.57	50.79
Prices/Earnings	417.13	148.61	28.74
Price/Sales	-25.52	4.20	5.64
Price/FCF	-6.34	-47.57	50.79
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-32.96	0.19	0.28
Operating Margin	-26.80	0.07	0.10
ROA	-77.67	< 0.005	< 0.005
ROE	0.02	< 0.005	-76.91
ROIC	0.01	0.01	-14.58
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	0.03	48.14
Dividends QOQ	< 0.005	0.00	inf
EBIT QOQ	-0.06	0.15	146.09
EPS QOQ	3.36	-0.75	-77.61
FCF QOQ	2.31	-2.25	-2.36
Revenue QOQ	-0.33	0.58	73.30
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	71.17	39.72	-44.19
Days Sales Outstanding (DSO)	111.90	77.48	-30.76
Inventory Turnover	1.26	2.27	79.18
Debt/Capitalization	0.58	0.59	2.40
Quick Ratio	0.78	0.83	5.65
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	66.36	65.22	-1.72
Cash	4.79	4.57	-4.57
Capex	-0.42	-1.10	-161.93
Free Cash Flow	2.68	-3.36	25.29
Revenue	24.17	38.08	57.55
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.19	1.25	5.53
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	22.33	34.29	53.51
Naive Interpretation	Member

06 - Financial Health · Weak

Rating